Volume 15, Number 2—February 2009
Research
Seoul Virus and Hantavirus Disease, Shenyang, People’s Republic of China
Table 2
Serum sample no. | IgM assay† |
IgG assay† |
|||
---|---|---|---|---|---|
SEOV | HTNV | SEOV | HTNV | ||
1/06 | 40 | 20 | 640 | 160 | |
2/06 | 40 | 20 | 320 | 80 | |
3/06 | 40 | – | 320 | 80 | |
4/06 | 20 | – | 320 | 160 | |
5/06 | 40 | – | 320 | 80 | |
6/06 | 40 | 20 | 160 | 20 | |
7/06 | 40 | 20 | 320 | 80 | |
8/06 | 40 | – | 320 | 160 |
*HFRS, hemorraghic fever with renal syndrome; IFA, immunofluorescent assay; Ig, immunoglobulin; SEOV, Seoul virus; HTNV, hantaan virus; –, could not be detected.
†Numbers represent the endpoint titers of anti-hantavirus (SEOV or HTNV) antibodies in the patients’ serum samples.
Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.